Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000031910Phase 4Not yet recruiting
Phase 4, randomised trial of nalbuphine in postoperative pain (8 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Visual Analog Scale. Planned start Apr 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000031910.